In the main purpose with the article the barriers to and facilitators of communication about potential long-term and late effects, post-treatment expectations, and transition to survivorship care have not been fully defined. According to the Institute of Medicine, high-quality cancer care should include effective communication between clinicians and patients about the risks and benefits, expected response, and impact on quality of life of a recommended therapy. 

Eight key informant interviews with medical oncologists and two focus groups with breast cancer survivors provided data. Both oncologists and patients perceived information on long-term effects as valuable in terms of improved clinical communication but had concerns about the feasibility of inclusion before treatment. They described the current approaches to communication of therapy risks as a brief laundry list that emphasized acute adverse effects and minimized more long-term issues

This experiment provides insight into oncologists’ communication with patients with breast cancer regarding the possible long-term and late effects of adjuvant chemotherapy and about setting realistic expectations for life after treatment

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374637/